Benefit and Harm of Aspirin on Mortality From Gastrointestinal Cancers Vs Bleeding in Helicobacter pylori-Eradicated Patients.
Ka Shing CheungBofei LiIan Yu-Hong WongSimon LawWai K LeungPublished in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (2024)
GI cancer mortality benefit from aspirin outweighs bleeding-related mortality in H pylori-eradicated subjects, which is enhanced further by PPI use.
Keyphrases
- cardiovascular events
- helicobacter pylori
- low dose
- end stage renal disease
- risk factors
- atrial fibrillation
- coronary artery disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiovascular disease
- papillary thyroid
- squamous cell carcinoma
- type diabetes
- lymph node metastasis
- acute coronary syndrome
- squamous cell
- percutaneous coronary intervention